APTEVO THERAPEUTICS INC. — Cash Flow Charts
30 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+31.8% +$2M
$-5M
Free Cash Flow↑+100.0% +$118K
$0
Investing Cash Flow
$0
Financing Cash Flow
$6M
Capex↓-100.0% -$118K
$0
Stock-Based Comp↑+100.6% +$179K
$357K
Debt Issued
$2M
Debt Repaid
$500K
D&A↓-37.1% -$95K
$161K
SBC Allocated Expense↑+100.0% +$179K
$358K